What is the ticker symbol for F-star Therapeutics?

F-star Therapeutics trades under the ticker FSTX on NASDAQ.

What sector does F-star Therapeutics operate in?

F-star Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze FSTX in a portfolio?

PortView shows FSTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

F-star Therapeutics (FSTX) Stock Analysis

NASDAQHealthcareBiotechnology

$7.12+0.00%

1-year price historyRange $2.18 – $7.12

52-week range$7.12

$2.07$7.12

What F-star Therapeutics does

F-star Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to inventing tetravalent bispecific antibodies for the treatment of cancer, particularly within the field of immuno-oncology. The company's primary investigational product, FS118, is currently in a Phase 2 proof-of-concept trial, evaluating its efficacy in head and neck cancer patients who have acquired resistance to PD-1/PD-L1 therapies. F-star is also advancing FS222, a bispecific antibody designed to simultaneously target the costimulatory CD137 receptor and the inhibitory PD-L1 ligand, through its initial Phase 1 human clinical study. Moreover, two additional drug candidates, FS120 and SB 11285, are undergoing Phase 1 clinical evaluation for patients with advanced malignancies. Founded in 2002, F-star Therapeutics, Inc. has its corporate headquarters situated in Cambridge, United Kingdom.

Key metrics

Market cap

$156.51M

P/E (TTM)

-3.89

EPS (TTM)

$-1.83

Beta

-0.35

Dividend yield

0.00%

Revenue / share

$1.27

50-day avg

$5.63

200-day avg

$5.74

52-week high

$7.12

52-week low

$2.07

CEO

Eliot Richard Forster

ETFs linked to FSTX

Broad-market and Healthcare sector ETFs an investor holding F-star Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how FSTX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze FSTX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for F-star Therapeutics?: F-star Therapeutics trades under the ticker FSTX on NASDAQ.
Which exchange is FSTX listed on?: FSTX is listed on NASDAQ.
What sector does F-star Therapeutics operate in?: F-star Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze FSTX in a portfolio?: PortView shows FSTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.